The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
ObjectiveAlanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD.MethodsWe conducted a retrospective anal...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1239398/full |
_version_ | 1797729010340331520 |
---|---|
author | Jiajun Qiu Jiajun Qiu Maobin Kuang Maobin Kuang Ruijuan Yang Ruijuan Yang Changhui Yu Changhui Yu Shiming He Shiming He Guotai Sheng Guotai Sheng Yang Zou |
author_facet | Jiajun Qiu Jiajun Qiu Maobin Kuang Maobin Kuang Ruijuan Yang Ruijuan Yang Changhui Yu Changhui Yu Shiming He Shiming He Guotai Sheng Guotai Sheng Yang Zou |
author_sort | Jiajun Qiu |
collection | DOAJ |
description | ObjectiveAlanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD.MethodsWe conducted a retrospective analysis of data from 14,251 individuals participating in the NAGALA project’s health screening program. The presence of NAFLD was diagnosed based on the participants’ alcohol consumption status and liver ultrasonography images. Multivariable logistic regression models were used to assess the association between the ALT/HDL-C ratio and NAFLD. Receiver operating characteristic (ROC) analysis was performed to determine and compare the effectiveness of ALT, HDL-C, the aspartate aminotransferase to HDL-C (AST/HDL-C) ratio, the gamma-glutamyl transferase to HDL-C (GGT/HDL-C) ratio and the ALT/HDL-C ratio in identifying NAFLD.ResultsWe observed a significant positive association between the ALT/HDL-C ratio and the prevalence of NAFLD. For each standard deviation (SD) increase in the ALT/HDL-C ratio, the adjusted odds ratio (OR) for NAFLD among the participants was 3.05 [95% confidence interval (CI): 2.63, 3.53], with the highest quartile of ALT/HDL-C ratio having a 9.96-fold increased risk compared to the lowest quartile. In further subgroup analyses stratified by gender, age, and waist circumference (WC), we observed a significantly higher risk of NAFLD associated with the ALT/HDL-C ratio among individuals aged ≥45 years, males, and those who were abdominal obesity. Furthermore, based on the results of ROC analysis, we found that the ALT/HDL-C ratio [area under the curves (AUC): 0.8553] was significantly superior to ALT, HDL-C, AST/HDL-C ratio and GGT/HDL-C ratio in identifying NAFLD (All Delong P<0.05); the threshold of suggested ALT/HDL-C ratio for identifying NAFLD was 15.97.ConclusionThis population-based study demonstrates a positive association between the ALT/HDL-C ratio and NAFLD. The ALT/HDL-C ratio can effectively identify individuals with NAFLD. |
first_indexed | 2024-03-12T11:22:39Z |
format | Article |
id | doaj.art-0c455dbeb7bd4dd89593b325ad1d443f |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-03-12T11:22:39Z |
publishDate | 2023-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-0c455dbeb7bd4dd89593b325ad1d443f2023-09-01T14:39:01ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-08-011410.3389/fendo.2023.12393981239398The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver diseaseJiajun Qiu0Jiajun Qiu1Maobin Kuang2Maobin Kuang3Ruijuan Yang4Ruijuan Yang5Changhui Yu6Changhui Yu7Shiming He8Shiming He9Guotai Sheng10Guotai Sheng11Yang Zou12Department of Internal Medicine, Medical College of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, ChinaJiangxi Cardiovascular Research Institute, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaDepartment of Internal Medicine, Medical College of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, ChinaJiangxi Cardiovascular Research Institute, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaDepartment of Internal Medicine, Medical College of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, ChinaDepartment of Endocrinology, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaDepartment of Internal Medicine, Medical College of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, ChinaJiangxi Cardiovascular Research Institute, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaDepartment of Internal Medicine, Medical College of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, ChinaJiangxi Cardiovascular Research Institute, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaJiangxi Provincial Geriatric Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaJiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaJiangxi Cardiovascular Research Institute, Jiangxi Provincial People’s Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, ChinaObjectiveAlanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD.MethodsWe conducted a retrospective analysis of data from 14,251 individuals participating in the NAGALA project’s health screening program. The presence of NAFLD was diagnosed based on the participants’ alcohol consumption status and liver ultrasonography images. Multivariable logistic regression models were used to assess the association between the ALT/HDL-C ratio and NAFLD. Receiver operating characteristic (ROC) analysis was performed to determine and compare the effectiveness of ALT, HDL-C, the aspartate aminotransferase to HDL-C (AST/HDL-C) ratio, the gamma-glutamyl transferase to HDL-C (GGT/HDL-C) ratio and the ALT/HDL-C ratio in identifying NAFLD.ResultsWe observed a significant positive association between the ALT/HDL-C ratio and the prevalence of NAFLD. For each standard deviation (SD) increase in the ALT/HDL-C ratio, the adjusted odds ratio (OR) for NAFLD among the participants was 3.05 [95% confidence interval (CI): 2.63, 3.53], with the highest quartile of ALT/HDL-C ratio having a 9.96-fold increased risk compared to the lowest quartile. In further subgroup analyses stratified by gender, age, and waist circumference (WC), we observed a significantly higher risk of NAFLD associated with the ALT/HDL-C ratio among individuals aged ≥45 years, males, and those who were abdominal obesity. Furthermore, based on the results of ROC analysis, we found that the ALT/HDL-C ratio [area under the curves (AUC): 0.8553] was significantly superior to ALT, HDL-C, AST/HDL-C ratio and GGT/HDL-C ratio in identifying NAFLD (All Delong P<0.05); the threshold of suggested ALT/HDL-C ratio for identifying NAFLD was 15.97.ConclusionThis population-based study demonstrates a positive association between the ALT/HDL-C ratio and NAFLD. The ALT/HDL-C ratio can effectively identify individuals with NAFLD.https://www.frontiersin.org/articles/10.3389/fendo.2023.1239398/fullALT/HDL-C ratioalanine aminotransferase to high-density lipoprotein cholesterol rationon-alcoholic fatty liver diseaseNAFLDALT to HDL-C ratio |
spellingShingle | Jiajun Qiu Jiajun Qiu Maobin Kuang Maobin Kuang Ruijuan Yang Ruijuan Yang Changhui Yu Changhui Yu Shiming He Shiming He Guotai Sheng Guotai Sheng Yang Zou The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease Frontiers in Endocrinology ALT/HDL-C ratio alanine aminotransferase to high-density lipoprotein cholesterol ratio non-alcoholic fatty liver disease NAFLD ALT to HDL-C ratio |
title | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_full | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_fullStr | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_full_unstemmed | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_short | The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease |
title_sort | newly proposed alanine aminotransferase to high density lipoprotein cholesterol ratio has shown effectiveness in identifying non alcoholic fatty liver disease |
topic | ALT/HDL-C ratio alanine aminotransferase to high-density lipoprotein cholesterol ratio non-alcoholic fatty liver disease NAFLD ALT to HDL-C ratio |
url | https://www.frontiersin.org/articles/10.3389/fendo.2023.1239398/full |
work_keys_str_mv | AT jiajunqiu thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT jiajunqiu thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT maobinkuang thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT maobinkuang thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT ruijuanyang thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT ruijuanyang thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT changhuiyu thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT changhuiyu thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT shiminghe thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT shiminghe thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT guotaisheng thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT guotaisheng thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT yangzou thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT jiajunqiu newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT jiajunqiu newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT maobinkuang newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT maobinkuang newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT ruijuanyang newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT ruijuanyang newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT changhuiyu newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT changhuiyu newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT shiminghe newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT shiminghe newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT guotaisheng newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT guotaisheng newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease AT yangzou newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease |